Fierce Healthcare

SEPTEMBER 10, 2021

AHA concerned federal vaccine mandate could exacerbate severe worker shortage. rking. Fri, 09/10/2021 - 16:09.

Vaccines 143

Vaccines 143

pharmaphorum

SEPTEMBER 8, 2021

Rapid creation of compliant marketing content is increasingly important and there are ways emerging pharma companies can stay ahead of the game – despite having fewer resources than bigger firms. A new pharma marketing content ebook from Veeva looks at best practices for building a content foundation that can enable long-term growth. It explains how to launch, scale faster, and improve the time to marker for localised, compliant content with cloud-based content management.

111

111

Outsourcing Pharma

SEPTEMBER 10, 2021

A leader from ACG Engineering shares insight on how âsmartâ drug manufacturing, accelerated by COVID-19, can best be put to work now and in months to come.

105

105

Pharma Mirror

SEPTEMBER 7, 2021

The Hague, Pharmacists must be allowed to do more to manage respiratory conditions in communities if the urgent need to address the harmful effects of air pollution on health is to be met, the International Pharmaceutical Federation (FIP) said today. The expansion of pharmacists’ roles in mitigating the health threats of air pollution is among several actions described in a call to action issued by FIP, marking the United Nations International Day of Clean Air for Blue Skies.

98

98

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Patient Care

Fierce Healthcare

SEPTEMBER 10, 2021

HHS releases $25.5B in COVID-19 relief funding targeted at smaller providers. rking. Fri, 09/10/2021 - 12:16.

139

139

pharmaphorum

SEPTEMBER 10, 2021

A digital health company focusing on neurodegenerative disorders – Neuroglee Therapeutics – has raised $10 million in first-round funding to roll out a virtual neurology clinics for people with cognitive problems caused by dementia. The Singapore startup, which is partnering with the Mayo Clinic on the clinics, said the cash injection will also go towards the development of its pipeline of digital therapeutics (DTx) for Alzheimer’s disease and other neurodegenerative conditions.

Mayo Clinic 105

Mayo Clinic Pharmaceutical Companies Pharmaceutical Companies FDA 105

Pharma Mirror

SEPTEMBER 7, 2021

Increasing burden of chronic diseases and rising awareness about necessity of early warning signs are fuelling the demand of remote patient monitors With the COVID-19 pandemic, health systems or hospitals rapidly adopted remote patient monitoring technology to maintain social distancing and thereby control viral spread. Patients suffering from COVID – 19 need to monitor blood oxygen level and heart rate regularly.

Hospitals 96

Hospitals 96

Fierce Healthcare

SEPTEMBER 9, 2021

SCAN Health Plan eyes expansion into Nevada, Arizona for 2022. pminemyer. Thu, 09/09/2021 - 14:36.

137

137

pharmaphorum

SEPTEMBER 8, 2021

A 20% to 25% reduction in staffing at the UK Medicines and Healthcare products Regulatory Agency (MHRA) risks undermining the ability of the authority to fulfil its role, according to trade unions. In an open letter to Health Secretary Sajid Javid, Prospect, Unite and three other unions say the decision to slash the MHRA’s current 1,200 workforce by up to 300 workers means that “regulatory decisions may suffer.” Fewer staff will therefore be asked to cover more ground with fewe

105

105

Outsourcing Pharma

SEPTEMBER 8, 2021

A leader from Illingworth Research Group outlines exactly what makes a good mobile research nurse and what their duties in decentralized trials are.

93

93

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

Pharma Times

SEPTEMBER 6, 2021

UK’s chief medical officers will now provide ‘further advice’ on COVID-19 vaccination in this age group

Vaccines 62

Vaccines 62

Fierce Healthcare

SEPTEMBER 8, 2021

Women’s health app Flo picks up $50M in fresh funding to fuel R&D, rapid growth. elucas. Wed, 09/08/2021 - 12:54.

137

137

pharmaphorum

SEPTEMBER 6, 2021

Amgen and partner AstraZeneca have said their recently filed severe asthma drug tezepelumab has shown impressive results in patients who also have nasal polyps, a common complication of the respiratory disease. Tezepelumab reduced the annualised asthma exacerbation rate (AAER) by 86% in a subgroup of people with severe, uncontrolled asthma and polyps in the NAVIGATOR study, topping the 41% reduction achieved with the first-in-class TSLP inhibitor in the overall study population.

Hospitals 105

Hospitals FDA 105

Outsourcing Pharma

SEPTEMBER 9, 2021

Nucala, a monoclonal antibody indicated for patients with chronic rhinosinusitis with nasal polyps, has been approved by the Food and Drug Administration.

FDA 91

FDA 91

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

FDA

Pharma Times

SEPTEMBER 6, 2021

New government body will be co-led by deputy chief medical officer Jeanelle de Gruchy

52

52

Fierce Healthcare

SEPTEMBER 9, 2021

Employers put focus on integrating wellbeing into benefits, survey finds. pminemyer. Thu, 09/09/2021 - 13:21.

136

136

pharmaphorum

SEPTEMBER 6, 2021

Mallinckrodt looks like it could join Purdue Pharma in reaching a settlement in its bankruptcy proceedings related to opioid litigation, after years of legal wrangling. The Ireland-headquartered drugmaker filed for bankruptcy last year, after proposing a $1.6 billion payout to settle lawsuits claiming that its marketing of opioid painkillers helped to fuel an epidemic in addiction that has claimed hundreds of thousands of lives in the US alone.

Documentation 98

Documentation Immunization 98

Outsourcing Pharma

SEPTEMBER 8, 2021

According to an Oracle Health Sciences leader, companies looking to take on decentralized trials should keep a few things in mind before taking the plunge.

78

78

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management Software

Impact Pharmaceutical Services

SEPTEMBER 10, 2021

RESEARCH TRIANGLE PARK, NC: 30 August 2021 – In the first half of 2021, IMPACT’s employees continued their generous efforts via the Making an IMPACT (MAI) community service initiative. As we all continued to work from home, our virtual charitable and community outreach efforts took new and creative forms! Valentine’s Day Cards In February, MAI […].

52

52

Fierce Healthcare

SEPTEMBER 9, 2021

Chutes & Ladders—Allina Health's CEO to retire; Centene refreshes its executive team. dmuoio. Thu, 09/09/2021 - 16:52.

135

135

pharmaphorum

SEPTEMBER 8, 2021

NICE has reversed its position on Johnson & Johnson’s oral prostate cancer therapy Erleada in patients with hormone-relapsed or hormone sensitive tumours, backing NHS use of the drug. The change of heart comes after J&J’s Janssen pharma unit offered an improved discount on Erleada (apalutamide), according to the cost-effectiveness watchdog in its final appraisal determination, which makes the drug an option for around 8,000 patients in England and Wales.

Chemotherapy 98

Chemotherapy 98

Outsourcing Pharma

SEPTEMBER 8, 2021

A representative from Cmed explains how taking stock of existing tech and adding the right new tools can help when switching to virtual clinical studies.

68

68

Dr. Jamie Hardy: The Lifestyle Pharmacist

SEPTEMBER 10, 2021

Being 40 ish and feeling FABULOUS is the mantra that I live by. Sure, changes are happening in my body and life that I have no control over. However, the way I choose to live through those changes is UP TO ME. I can be joyful or judgmental. I can be motivated or mopey. I can even be grateful or gloomy. The choice really is mine. So, I’m choosing to see myself as a beautiful rose that continues to bloom no matter what comes my way.

52

52

Fierce Healthcare

SEPTEMBER 10, 2021

House lawmakers clash over impact of adding dental, vision and hearing benefits to Medicare. rking. Fri, 09/10/2021 - 15:52.

134

134

pharmaphorum

SEPTEMBER 7, 2021

Servier and Neurochlore have been forced to admit defeat in their bid to bring the first drug to market for people with autism spectrum disorder (ASD), after a comprehensive fail for their bumetanide candidate in two phase 3 trials. The French partners said today that there was “no sign of effectiveness” for bumetanide compared to placebo in 422 children and adolescents with ASD enrolled in the two studies, which have now been halted.

FDA 97

FDA 97

Outsourcing Pharma

SEPTEMBER 7, 2021

A leader from the home trial services provder says patientsâ increasing awareness of clinical research has how trial teams should consider their approach.

63

63

Turnkey Pharmacy Solutions

SEPTEMBER 9, 2021

“One-Fourth of 340B DSH Hospitals at Risk of Losing Eligibility Due to Pandemic, Analysis Finds.” This is a shocking headline that recently caught my eye as I was perusing the 340B Report. The article further goes on to explain that an analysis of hospital Medicare cost reports for 2019 and 2020 show that about one.

Hospitals 52

Hospitals 52

Fierce Healthcare

SEPTEMBER 10, 2021

Ginger's mental health app now available in Spanish with full rollout to all 25M users by early 2022. hlandi. Fri, 09/10/2021 - 16:46.

131

131

pharmaphorum

SEPTEMBER 10, 2021

Shares in Biogen have come under pressure after chief executive Michel Vounatsos admitted that the company is facing a much slower than anticipated rollout of its controversial Alzheimer’s disease therapy Aduhelm. Speaking at a Morgan Stanley conference yesterday, Vounatsos said Biogen may have to revisit its sales forecasts for Aduhelm (aducanumab), which were already “very low.” He blamed the poor performance on ” confusion, misinformation and controversy surrounding ou

Labelling 96

Labelling Insurance FDA 96

Outsourcing Pharma

SEPTEMBER 7, 2021

The trial tech firm says analysis of trials in low- and middle-income regions reveals that innovative statistical methods could make a huge difference.

59

59

Pharma Mirror

SEPTEMBER 9, 2021

Sterling Pharma Solutions, a global contract development and manufacturing organisation, today announced the completion of the initial phase of investment at its site in Dudley, UK to create the company’s centre of excellence for research into commercial applications of continuous flow chemistry. Announcement of the investment follows the appointment of Professor Ian R.

Research Laboratories 52

Research Laboratories 52

Fierce Healthcare

SEPTEMBER 9, 2021

Cigna, Oscar Health expanding cobranded plans into Illinois. pminemyer. Thu, 09/09/2021 - 11:50.

130

130

pharmaphorum

SEPTEMBER 6, 2021

BioMarin Pharma has had another setback in its gene therapy development programme, announcing this morning that the FDA has placed a phase 1/2 trial of its candidate for phenylketonuria (PKU) on hold while it investigates a safety signal. The biotech said that the US regulator ordered the pause on the study after liver tumours were seen in mice given the therapy in preclinical testing.

FDA 94

FDA 94